+467.0%
MRNA vs MKC
-23.2%
+490.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MKC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.4% | +4.9% | +5.2% |
| 7D | -1.1% | -1.5% | +0.4% | -0.6% |
| 30D | +126.1% | -3.1% | +129.2% | +134.3% |
| 3M | +190.0% | +5.2% | +184.8% | +202.5% |
| 6M | +157.2% | -12.8% | +170.0% | +161.1% |
| YTD | +388.2% | -23.3% | +411.5% | +389.5% |
| 1Y | +467.0% | -24.1% | +491.1% | +478.0% |
| All | +467.0% | -23.2% | +490.2% | +478.0% |
Cumulative growth
Daily Returns
Daily percentage return beside MKC.
Daily Out/Under-Performance
Portfolio return minus MKC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MKC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MKC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling